According to a recent LinkedIn post from Glooko, the company has been selected as the winner of the “Best Overall MedTech Software” award in the 10th annual MedTech Breakthrough Awards. The post highlights that the recognition relates to Glooko’s connected care software suite for simplifying diabetes and glycemic management across inpatient and outpatient settings.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The post suggests that this third‑party validation could strengthen Glooko’s competitive positioning in digital diabetes and broader MedTech software markets. For investors, such recognition may support the company’s ability to win new healthcare provider, hospital, and health‑system customers, potentially improving commercial traction and enhancing its appeal as a partner within the diabetes care ecosystem.